Comparative genomic analysis of primary tumors and metastases in breast cancer-Reference-Cited by-同舟云学术

Comparative genomic analysis of primary tumors and metastases in breast cancer

Published:2016-03-25 Issue:19 Volume:7 Page:27208-27219
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bertucci François¹²³,Finetti Pascal¹,Guille Arnaud¹,Adélaïde José¹,Garnier Séverine¹,Carbuccia Nadine¹,Monneur Audrey¹²,Charafe-Jauffret Emmanuelle¹³⁴,Goncalves Anthony²³,Viens Patrice²³,Birnbaum Daniel¹,Chaffanet Max¹

Affiliation:

1. Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France

2. Département d'Oncologie Médicale, CRCM, Institut Paoli-Calmettes, Marseille, France

3. Faculté de Médecine, Aix-Marseille Université, Marseille, France

4. Département de Biopathologie, CRCM, Institut Paoli-Calmettes, Marseille, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer metastasis: Molecular mechanisms and clinical perspectives;Pharmacology & Therapeutics;2023-10

2. Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2023-07-01

3. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network;Journal of Translational Medicine;2023-06-23

4. Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer;Genes & Genomics;2023-06-05

5. BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib;Frontiers in Oncology;2023-03-17